MAXALT should not be given to patients with ischemic heart disease (e.g., angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have symptoms or findings consistent with ischemic heart disease, coronary artery vasospasm, including Prinzmetal's variant angina, or other significant underlying cardiovascular disease. MAXALT should not be administered to patients with hemiplegic or basilar migraine.

US Pharm. 2008;33(5):18-21.

Clotting events appear to be rare with Clomid®, and it is not known whether they are coincidental or causatively related. There is, therefore, no clear indication for a patient like the one above to be on a blood thinner while taking Clomid®. Blood thinners may, actually, increase the risk of bleeding into the developing ovarian follicle and, thus, cause unwanted side effects. Weighing the risk and benefit it may be appropriate not to have this patient on blood thinners during Clomid® therapy, but only during pregnancy. Last Updated: 12/22/06

The Female Patient.

Prescribing Information

January 03, 2007

Joint Bone Spine. Volume 74, Issue 1 , January 2007, Pages 4-6.

US Pharm. 2008;33(5):18-21. W. Steven Pray, PhD, DPh, Bernhardt Professor of Nonprescription Drugs and Devices, College of Pharmacy, Southwestern Oklahoma State University, Weatherford, Oklahoma

WebMD Health

Updated Oct 2006. Written by Michael Cannon, MD, and reviewed by the American College of Rhematology Patient Education Task Force.

This medicine contains the active ingredient dipyridamole, which is a type of medicine known as an antiplatelet agent. It prevents blood cells called platelets from clumping together inside the blood vessels, and is sometimes referred to as a 'blood thinner'. It also dilates the blood vessels.

AXERT® (almotriptan malate) Tablets should not be given to patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), or to patients who have symptoms or findings consistent with ischemic heart disease, coronary artery vasospasm, including Prinzmetal's variant angina, or other significant underlying cardiovascular disease. AXERT® should not be given to patients with hemiplegic or basilar migraine.

Revised: 12/2003

WebMD Health

Do not use FROVA if you have uncontrolled high blood pressure; have heart disease or a history of heart disease; have had a stroke; have circulation (blood flow) problems; or have hemiplegic or basilar migraine (if you are not sure about this, ask your doctor). If you're taking a selective serotonin reuptake inhibitor (SSRI) or another medication to treat depression, talk to your doctor before taking FROVA. Do not take FROVA if you have an allergic reaction to the tablet or within 24 hours of taking any triptans or ergotamine medications. The most common side effects associated with the use of FROVA are dizziness, tiredness, feeling of tingling, hot flashes, headache (other than migraine headache), dry mouth, hot or cold sensation, pain in joints or bones, chest pain, and indigestion.

CHEST, Feb, 2005 by John R. Bartholomew

US Pharm. 2008;33(5):44-56. CONCLUSION: OTC pain medications should be used at the lowest effective dose for the shortest duration possible to minimize the potential risk for an adverse event. Patients taking acetaminophen should not exceed the recommended maximum daily dose, while patients taking NSAIDs should not exceed the recommended single or daily dose. Doses given to children and infants should be very carefully measured, with the dosing device that comes packaged with the drug product. Labels for prescription medications containing OTC ingredients should be clear and should not contain abbreviations such as APAP. Patient and consumer education is also essential in preventing damage caused by these seemingly harmless medications. The pharmacist has a great opportunity to intervene. Encourage patients who take prescription medications containing acetaminophen or an NSAID to pay special attention to the ingredients on any OTC medication labels they are also using to reduce the incidence of accidental analgesic overdosing. Provide educational materials to patients so that they may learn to recognize the generic names of these medications. Warn consumers of the risks of misusing OTC pain relievers. While these drugs are safe and effective when taken at recommended doses, they may be quite harmful, even fatal, when taken inappropriately. Pharmacists can make a critically important contribution to the safety of patients taking acetaminophen- and NSAID-containing products. It is our duty to help patients use OTC medications safely.